- A Chinses vaccine against coronavirus presently in a trial in Brazil has gone into a third-approval phase
- Called the CoronaVac, if the final test goes well, there could be mass production of 120 million doses
- Test results of the promising vaccine according to a health official, Joao Doria, is expected to be ready within three months
PAY ATTENTION: Click “See First” under the “Following” tab to see Briefly.co.za News on your News Feed!
A Chinese-made vaccine against Covid-19 went into its final phase of test on Tuesday, July 21 in Brazil as volunteers believe it would go a long way in ending the pandemic.
The vaccine was developed by a private Chinese firm called Sinovac, making it the third vaccine in the world to enter Phase 3 clinical trial on humans, How Africa reports.
“We’re living in unique and historic times, and that’s why I wanted to be part of this trial,” said the 27-year-old doctor who received the first dose said.
Known as CoronaVac, about 9,000 health workers across six Brazillian states will get the vaccine in two doses over the space of three months.
The governor of Sao Paulo hospital, Joao Doria on Monday, July 20, said that the test results of thee vaccines are expected back within 90 days.
In the case that the vaccine proves effective against Covid-19, the institute in charge will be given the right to mass-produce 120 million doses.
READ ALSO: Videos show people dancing at Papers 707's funeral, SA reacts
Meanwhile, Briefly.co.za earlier reported that two Covid-19 vaccine candidates showed positive results in separate trials across the world.
In Britain, a trial saw 1,000 adults participating and had found that the vaccine had induced 'strong antibody and immune responses'.
Another trial took place in China and saw over 500 people taking part. This trial had also shown that most participants had developed a positive response against the virus.
READ ALSO: Lerato Kganyago gets engaged, again: Peeps can’t even believe it
Both possible vaccines have proven safe for human use and trials found that they had both produced strong immune reactions, according to doctors.
In other related news, the African Development Bank has green-lighted a R5 billion loan to South Africa to help it win the battle against Covid-19.
In addition to funding this battle, the loan will also help SA mitigate the economic fallout the pandemic has brought with it. After the SA government requested aid from the bank, it released a statement on the approval of the loan:
“The board of directors of the African Development Bank (AfDB) has approved a loan of approximately R5 billion ($288 million) to the government of South Africa, as the country battles one of the largest COVID-19 caseloads in the world."
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!